These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25531135)

  • 1. Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase.
    Ogese MO; Jenkins RE; Maggs JL; Meng X; Whitaker P; Peckham D; Faulkner L; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2015 Jan; 28(1):144-54. PubMed ID: 25531135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.
    Elsheikh A; Lavergne SN; Castrejon JL; Farrell J; Wang H; Sathish J; Pichler WJ; Park BK; Naisbitt DJ
    J Immunol; 2010 Dec; 185(11):6448-60. PubMed ID: 20980635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
    Vyas PM; Roychowdhury S; Koukouritaki SB; Hines RN; Krueger SK; Williams DE; Nauseef WM; Svensson CK
    J Pharmacol Exp Ther; 2006 Oct; 319(1):497-505. PubMed ID: 16857727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing
    Pratoomwun J; Thomson P; Jaruthamsophon K; Tiyasirichokchai R; Jinda P; Rerkpattanapipat T; Tassaneeyakul W; Nakkam N; Rerknimitr P; Klaewsongkram J; Srinoulprasert Y; Pirmohamed M; Naisbitt DJ; Sukasem C
    Front Immunol; 2021; 12():658593. PubMed ID: 33995375
    [No Abstract]   [Full Text] [Related]  

  • 5. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
    Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
    Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
    Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
    Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.
    Lavergne SN; Wang H; Callan HE; Park BK; Naisbitt DJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):372-81. PubMed ID: 19666748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
    Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
    Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.
    Schnyder B; Burkhart C; Schnyder-Frutig K; von Greyerz S; Naisbitt DJ; Pirmohamed M; Park BK; Pichler WJ
    J Immunol; 2000 Jun; 164(12):6647-54. PubMed ID: 10843725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo.
    Tailor A; Waddington JC; Hamlett J; Maggs J; Kafu L; Farrell J; Dear GJ; Whitaker P; Naisbitt DJ; Park K; Meng X
    Chem Res Toxicol; 2019 Oct; 32(10):2095-2106. PubMed ID: 31468968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
    Ogese MO; Saide K; Faulkner L; Whitaker P; Peckham D; Alfirevic A; Baker DM; Sette A; Pirmohamed M; Park BK; Naisbitt DJ
    Clin Exp Allergy; 2015 Aug; 45(8):1305-16. PubMed ID: 25851465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
    Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
    Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
    Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.
    Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK
    Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides.
    Burkhart C; Britschgi M; Strasser I; Depta JP; von Greyerz S; Barnaba V; Pichler WJ
    Clin Exp Allergy; 2002 Nov; 32(11):1635-43. PubMed ID: 12569986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
    Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
    Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
    Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
    Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
    Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
    Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.